Skip to main content
. 2019 Dec 24;9(1):58. doi: 10.3390/cells9010058

Figure 1.

Figure 1

Pancreatic ductal adenocarcinoma (PDAC) heterogeneity in KrasG12D/+;LSL-Trp53R172H/+;Pdx-1-Cre (KPC) mouse model. (A) Survival of KPC cohort (n = 46) with median survival of 160 days. (B) PDAC establishment histopathologically confirmed and respective tumors graded.